Logo image of ELV

ELEVANCE HEALTH INC (ELV) Stock Fundamental Analysis

NYSE:ELV - New York Stock Exchange, Inc. - US0367521038 - Common Stock - Currency: USD

390.5  -1.21 (-0.31%)

Premarket: 386 -4.5 (-1.15%)

Fundamental Rating

5

Overall ELV gets a fundamental rating of 5 out of 10. We evaluated ELV against 108 industry peers in the Health Care Providers & Services industry. While ELV is still in line with the averages on profitability rating, there are concerns on its financial health. ELV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ELV had positive earnings in the past year.
ELV had a positive operating cash flow in the past year.
In the past 5 years ELV has always been profitable.
In the past 5 years ELV always reported a positive cash flow from operatings.
ELV Yearly Net Income VS EBIT VS OCF VS FCFELV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

The Return On Assets of ELV (5.13%) is better than 79.44% of its industry peers.
The Return On Equity of ELV (14.47%) is better than 83.18% of its industry peers.
With a decent Return On Invested Capital value of 5.92%, ELV is doing good in the industry, outperforming 68.22% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ELV is in line with the industry average of 8.14%.
Industry RankSector Rank
ROA 5.13%
ROE 14.47%
ROIC 5.92%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.7%
ROIC(5y)7.07%
ELV Yearly ROA, ROE, ROICELV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ELV has a Profit Margin of 3.38%. This is in the better half of the industry: ELV outperforms 72.90% of its industry peers.
In the last couple of years the Profit Margin of ELV has declined.
With a decent Operating Margin value of 5.03%, ELV is doing good in the industry, outperforming 63.55% of the companies in the same industry.
In the last couple of years the Operating Margin of ELV has declined.
Industry RankSector Rank
OM 5.03%
PM (TTM) 3.38%
GM N/A
OM growth 3Y-8.69%
OM growth 5Y-5.02%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
ELV Yearly Profit, Operating, Gross MarginsELV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELV is destroying value.
The number of shares outstanding for ELV has been reduced compared to 1 year ago.
The number of shares outstanding for ELV has been reduced compared to 5 years ago.
The debt/assets ratio for ELV is higher compared to a year ago.
ELV Yearly Shares OutstandingELV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
ELV Yearly Total Debt VS Total AssetsELV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

ELV has a debt to FCF ratio of 6.96. This is a slightly negative value and a sign of low solvency as ELV would need 6.96 years to pay back of all of its debts.
ELV's Debt to FCF ratio of 6.96 is fine compared to the rest of the industry. ELV outperforms 67.29% of its industry peers.
ELV has a Debt/Equity ratio of 0.72. This is a neutral value indicating ELV is somewhat dependend on debt financing.
ELV has a Debt to Equity ratio (0.72) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.96
Altman-Z N/A
ROIC/WACC0.71
WACC8.28%
ELV Yearly LT Debt VS Equity VS FCFELV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ELV Yearly Current Assets VS Current LiabilitesELV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

6

3. Growth

3.1 Past

ELV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.42%.
ELV shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.17% yearly.
ELV shows a small growth in Revenue. In the last year, the Revenue has grown by 3.19%.
The Revenue has been growing by 11.14% on average over the past years. This is quite good.
EPS 1Y (TTM)-0.42%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-31.67%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%5.97%

3.2 Future

ELV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.21% yearly.
ELV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.91% yearly.
EPS Next Y4.61%
EPS Next 2Y9.38%
EPS Next 3Y12.04%
EPS Next 5Y14.21%
Revenue Next Year9.97%
Revenue Next 2Y8.62%
Revenue Next 3Y8.91%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ELV Yearly Revenue VS EstimatesELV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B
ELV Yearly EPS VS EstimatesELV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60 80

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.84 indicates a reasonable valuation of ELV.
88.78% of the companies in the same industry are more expensive than ELV, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 30.30. ELV is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 11.32, which indicates a very decent valuation of ELV.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELV indicates a rather cheap valuation: ELV is cheaper than 86.92% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.06. ELV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.84
Fwd PE 11.32
ELV Price Earnings VS Forward Price EarningsELV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ELV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ELV is cheaper than 73.83% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ELV indicates a somewhat cheap valuation: ELV is cheaper than 73.83% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.19
EV/EBITDA 11.01
ELV Per share dataELV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as ELV's earnings are expected to grow with 12.04% in the coming years.
PEG (NY)2.57
PEG (5Y)1.06
EPS Next 2Y9.38%
EPS Next 3Y12.04%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.75%, ELV has a reasonable but not impressive dividend return.
ELV's Dividend Yield is rather good when compared to the industry average which is at 2.95. ELV pays more dividend than 86.92% of the companies in the same industry.
ELV's Dividend Yield is slightly below the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 1.75%

5.2 History

On average, the dividend of ELV grows each year by 15.12%, which is quite nice.
ELV has paid a dividend for at least 10 years, which is a reliable track record.
ELV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.12%
Div Incr Years13
Div Non Decr Years13
ELV Yearly Dividends per shareELV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ELV pays out 25.22% of its income as dividend. This is a sustainable payout ratio.
The dividend of ELV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP25.22%
EPS Next 2Y9.38%
EPS Next 3Y12.04%
ELV Yearly Income VS Free CF VS DividendELV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
ELV Dividend Payout.ELV Dividend Payout, showing the Payout Ratio.ELV Dividend Payout.PayoutRetained Earnings

ELEVANCE HEALTH INC

NYSE:ELV (2/20/2025, 8:13:17 PM)

Premarket: 386 -4.5 (-1.15%)

390.5

-1.21 (-0.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-23 2025-01-23/bmo
Earnings (Next)07-15 2025-07-15/amc
Inst Owners92.13%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner Change-1.88%
Market Cap90.56B
Analysts77.86
Price Target504.77 (29.26%)
Short Float %1.22%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield 1.75%
Yearly Dividend6.49
Dividend Growth(5Y)15.12%
DP25.22%
Div Incr Years13
Div Non Decr Years13
Ex-Date03-10 2025-03-10 (1.71)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.02%
Min EPS beat(2)-14.2%
Max EPS beat(2)0.17%
EPS beat(4)3
Avg EPS beat(4)-3.47%
Min EPS beat(4)-14.2%
Max EPS beat(4)0.17%
EPS beat(8)6
Avg EPS beat(8)-0.87%
EPS beat(12)9
Avg EPS beat(12)0.38%
EPS beat(16)12
Avg EPS beat(16)1.63%
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-0.71%
Max Revenue beat(2)2.1%
Revenue beat(4)1
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-1.81%
Max Revenue beat(4)2.1%
Revenue beat(8)3
Avg Revenue beat(8)0.42%
Revenue beat(12)6
Avg Revenue beat(12)0.46%
Revenue beat(16)8
Avg Revenue beat(16)0.22%
PT rev (1m)-2.88%
PT rev (3m)-10.36%
EPS NQ rev (1m)3.29%
EPS NQ rev (3m)-8.91%
EPS NY rev (1m)-2.33%
EPS NY rev (3m)-2.3%
Revenue NQ rev (1m)1.19%
Revenue NQ rev (3m)3.16%
Revenue NY rev (1m)2.18%
Revenue NY rev (3m)2.27%
Valuation
Industry RankSector Rank
PE 11.84
Fwd PE 11.32
P/S 0.51
P/FCF 20.19
P/OCF 15.77
P/B 2.19
P/tB 95.94
EV/EBITDA 11.01
EPS(TTM)32.97
EY8.44%
EPS(NY)34.49
Fwd EY8.83%
FCF(TTM)19.34
FCFY4.95%
OCF(TTM)24.76
OCFY6.34%
SpS762.37
BVpS178.14
TBVpS4.07
PEG (NY)2.57
PEG (5Y)1.06
Profitability
Industry RankSector Rank
ROA 5.13%
ROE 14.47%
ROCE 7.75%
ROIC 5.92%
ROICexc 6.38%
ROICexgc 11.45%
OM 5.03%
PM (TTM) 3.38%
GM N/A
FCFM 2.54%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.7%
ROIC(5y)7.07%
ROICexc(3y)7.22%
ROICexc(5y)7.58%
ROICexgc(3y)13.28%
ROICexgc(5y)14.25%
ROCE(3y)8.77%
ROCE(5y)9.24%
ROICexcg growth 3Y-10.15%
ROICexcg growth 5Y-6.05%
ROICexc growth 3Y-8.21%
ROICexc growth 5Y-4.22%
OM growth 3Y-8.69%
OM growth 5Y-5.02%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.52
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.96
Debt/EBITDA 2.88
Cap/Depr 90.17%
Cap/Sales 0.71%
Interest Coverage 250
Cash Conversion 55.85%
Profit Quality 75.02%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC8.28%
ROIC/WACC0.71
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.42%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-31.67%
EPS Next Y4.61%
EPS Next 2Y9.38%
EPS Next 3Y12.04%
EPS Next 5Y14.21%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%5.97%
Revenue Next Year9.97%
Revenue Next 2Y8.62%
Revenue Next 3Y8.91%
Revenue Next 5YN/A
EBIT growth 1Y-6.41%
EBIT growth 3Y-0.98%
EBIT growth 5Y5.56%
EBIT Next Year10.49%
EBIT Next 3Y11.08%
EBIT Next 5Y9.84%
FCF growth 1Y-33.69%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-28.77%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%